Outcomes of SARS-CoV-2 and Seasonal Viruses Among Children Hospitalized in Brazil
CS Dias, LM Diniz, MCL Oliveira… - …, 2024 - publications.aap.org
BACKGROUND AND OBJECTIVES Understanding how severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) interacts with other respiratory viruses is crucial for developing …
coronavirus 2 (SARS-CoV-2) interacts with other respiratory viruses is crucial for developing …
Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic
Background Since the beginning of the COVID-19 pandemic, patients with Inborn Errors of
Immunity have been infected by SARS-CoV-2 virus showing a spectrum of disease ranging …
Immunity have been infected by SARS-CoV-2 virus showing a spectrum of disease ranging …
Clinical outcomes of Omicron variant (B. 1.1. 529) infection in children and adolescents hospitalized with COVID-19 in Brazil with observational data on the efficacy of …
Since the beginning of the COVID-19 pandemic, variants of SARS-CoV-2 have emerged
and spread around the world, contributing to the cyclic waves of infection that occur …
and spread around the world, contributing to the cyclic waves of infection that occur …
A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey
D Yılmaz, G Üstündağ, A Büyükçam, E Salı… - European journal of …, 2023 - Springer
This multi-center point prevalence study evaluated children who were diagnosed as having
coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients …
coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients …
Effect of obesity on COVID-19 disease severity in children
Abstract Introduction: Coronavirus disease 2019 (COVID-19) has caused many injuries and
deaths worldwide. Obesity is reported to be an important risk factor for severe COVID-19 …
deaths worldwide. Obesity is reported to be an important risk factor for severe COVID-19 …
A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine: For 18-25-Year-Old Males, Risks Exceeded Benefits Relative to …
PS Bourdon, R Duriseti, HC Gromoll, DK Dalton… - arXiv preprint arXiv …, 2024 - arxiv.org
The FDA conducted a benefit-risk assessment for Moderna's COVID vaccine mRNA-1273
prior to its full approval (announced 1/31/2022). The FDA focused its assessment on males …
prior to its full approval (announced 1/31/2022). The FDA focused its assessment on males …
[PDF][PDF] COVID-19 pediátrico
MPL Castellanos, MRA Ballesteros - Pediatría Integral, 2023 - pediatriaintegral.es
COVID-19 emerged in China in December 2019, producing cases of severe pneumonia. It
quickly spread worldwide, creating a pandemic transcending the healthcare field with …
quickly spread worldwide, creating a pandemic transcending the healthcare field with …